Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
[Natalizumab and reduction of carbonylated proteins in patients with multiple sclerosis].
Genetic characterization of gliomas arising in patients with multiple sclerosis.
A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Gammaherpesvirus Infection of Human Neuronal Cells.
Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Functional identification of neural stem cell-derived oligodendrocytes.
Development of nucleic acid drugs for neurological disorders.
Spasticity: pathophysiology, evaluation and management.
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
The Diagnostic Accuracy of Static Posturography in Predicting Accidental Falls in People With Multiple Sclerosis.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Dark microglia: A new phenotype predominantly associated with pathological states.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Pages
« first
‹ previous
…
223
224
225
226
227
228
229
230
231
…
next ›
last »